Table 1 from Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Should I take a Cancer Marker Test? | Positive Bioscience
Table 1 from Cancer antigens 19-9 and 125 in the differential diagnosis of pancreatic mass lesions. | Semantic Scholar
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis | SpringerLink
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Biomolecular recognition of the glycan neoantigen CA19-9 by distinct antibodies | bioRxiv
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
CA 19-9 Antigen - an overview | ScienceDirect Topics
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection - ScienceDirect
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
![PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1144a56968788915c60eb298e39fcf2d60c86823/5-Table2-1.png "PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar")
PDF] False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. | Semantic Scholar
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA | BMC Medicine | Full Text
CA19-9 - Wikipedia
The Highest Ever Reported Level of Carbohydrate Antigen 19-9: A Case Report | Al-Khallaf | Journal of Medical Cases
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
